ArticleSurgical endoscopy2026
Risk of metachronous advanced neoplasia was comparable between patients with 1-2 and 3-4 non-advanced adenomas removed during screening colonoscopy.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundCurrent post-polypectomy guidelines classified 3-4 non-advanced adenomas (NAAs) as carrying an intermediate risk of metachronous advanced colorectal neoplasia (ACRN), positioned between that of 1-2 NAAs and > 4 NAAs. However, emerging evidence suggested that individuals with 3-4 NAAs may have a risk comparable to those with 1-2 NAAs. This study aimed to compare the risk of metachronous ACRN between individuals with 1-2 NAAs and 3-4 NAAs.
methodsA two-center retrospective cohort study of individuals with NAAs and subsequent surveillance colonoscopy was conducted. Cox regression models were used to compare the risk of metachronous colorectal neoplasia (CRN) and ACRN between individuals with 1-2 and 3-4 NAAs.
results2955 individuals who had NAAs removed during baseline colonoscopy were included. The risk of metachronous CRN in individuals with 1-2 NAAs was significantly lower than that in those with 3-4 NAAs (adjusted HR (95% CI), 1.28(1.04-1.57)) and those with > 4 NAAs (adjusted HR (95% CI), 1.52(1.10-2.10)), while the cumulative incidence and risk of metachronous ACRN in individuals with 1-2 NAAs was comparable with that in those with 3-4 NAAs (adjusted HR (95% CI), 0.64(0.18-2.23)) and significantly lower than that in those with > 4 NAAs (adjusted HR (95% CI), 4.69(1.51-14.6)).
conclusionsIn this observational study, the risk of metachronous ACRN after removal of 1-2 and 3-4 NAAs was comparable and lower than that observed after removal of > 4 NAAs. These findings suggest that individuals with 3-4 NAAs may have a similar risk profile to those with 1-2 NAAs. Further prospective studies are warranted to determine the optimal surveillance interval for this subgroup.
Indexed as
Identifiers
41772221What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.